Published February 8, 2021
| Version v1
Figure
Open
Preclinical evaluation of the association of the cyclin-dependent kinase 4/6 inhibitor ribociclib and cetuximab in squamous cell carcinoma of the head and neck.
Creators
- 1. Université catholique de Louvain (UCLouvain)
- 2. Université Libre de Bruxelles (ULB)
Description
Supplementary data
Files
FigS1.png
Files
(2.7 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:bc4bf116da57eb9efc6efece4cc4c59b
|
944.1 kB | Preview Download |
|
md5:fd62b0226b13e0e845f60874e65d6838
|
201.1 kB | Preview Download |
|
md5:4b3ebe34ac91411f7d430ffada2617f7
|
158.6 kB | Preview Download |
|
md5:c842d5c861f08786876a88bd3b02c4c7
|
275.4 kB | Preview Download |
|
md5:a34e555cdcc07b6b4e79315fa53bbffe
|
267.9 kB | Preview Download |
|
md5:277f28d1a2b9088b608354143eeba009
|
199.5 kB | Preview Download |
|
md5:7cb77b813c13e2bbdb6dcd6f16ed42a9
|
157.4 kB | Preview Download |
|
md5:96a6148ffd1bf6db5a0178417966b818
|
270.2 kB | Preview Download |
|
md5:e134ccd177a7777504e1867be74abd33
|
266.9 kB | Preview Download |
